GILD:NSD-Gilead Sciences Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 111.44

Change

0.00 (0.00)%

Market Cap

USD 142.46B

Volume

8.65M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-16 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 240.59B
AMGN Amgen Inc

N/A

USD 162.78B
SNY Sanofi ADR

N/A

USD 148.55B
BIIB Biogen Inc

N/A

USD 20.57B
GRFS Grifols SA ADR

N/A

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.25B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

IBBQ Invesco Nasdaq Biotechnol.. 10.43 % 0.00 %

N/A

USD 0.04B
2B70:F iShares NASDAQ US Biotech.. 10.40 % 0.00 %

N/A

USD 0.52B
2B70:XETRA iShares Nasdaq US Biotech.. 10.33 % 0.00 %

N/A

USD 0.52B
BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
KNGU:CA Brompton U.S. Cash Flow K.. 4.34 % 0.00 %

N/A

CAD 0.01B
FBT:LSE First Trust Global Funds .. 4.31 % 0.00 %

N/A

USD 8.62M
FBTU:LSE First Trust Global Funds .. 4.31 % 0.00 %

N/A

USD 8.52M
QQQG Pacer Nasdaq 100 Top 50 C.. 4.05 % 0.00 %

N/A

USD 2.69M
UDI USCF ETF Trust 4.00 % 0.00 %

N/A

N/A
JPHC:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.52M
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.51M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.92M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.95B
TBG EA Series Trust 3.79 % 0.00 %

N/A

USD 0.12B
SAMM The Advisors’ Inner .. 3.69 % 0.00 %

N/A

USD 0.02B
MOTV:LSE VanEck Morningstar US Wid.. 3.48 % 0.00 %

N/A

USD 0.06B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

N/A

N/A
BAMD Brookstone Dividend Stock.. 3.34 % 0.00 %

N/A

USD 0.09B
MDLV EA Series Trust - Morgan .. 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
QNXT iShares Nasdaq-100 ex Top.. 3.18 % 0.00 %

N/A

USD 0.01B
WTD9:F WisdomTree US Equity Inco.. 2.94 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.94 % 0.00 %

N/A

USD 1.44M
WTEU:F WisdomTree US Equity Inco.. 2.94 % 0.00 %

N/A

USD 0.11B
MVFD Northern Lights Fund Trus.. 2.87 % 0.00 %

N/A

USD 0.07B
MHOT:AU VanEck Morningstar Wide M.. 2.76 % 0.00 %

N/A

N/A
MOTU:LSE VanEck Morningstar US Wid.. 2.76 % 0.00 %

N/A

USD 0.06B
2B78:XETRA iShares Healthcare Innova.. 2.75 % 0.00 %

N/A

USD 1.05B
MOAT:AU VanEck Morningstar Wide M.. 2.74 % 0.00 %

N/A

USD 1.09B
INVN The Alger ETF Trust 2.69 % 0.00 %

N/A

N/A
QUVU Hartford Quality Value ET.. 2.55 % 0.00 %

N/A

USD 0.18B
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 2.44 % 1.07 %

N/A

USD 0.03B
HDCH:SW Invesco S&P 500 High Divi.. 2.43 % 0.00 %

N/A

USD 4.51M
CURE:AU ETFS S&P Biotech ETF 2.42 % 0.00 %

N/A

USD 0.04B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.38 % 0.00 %

N/A

USD 0.08B
HWVS:LSE HSBC MSCI World Value ESG.. 2.25 % 0.00 %

N/A

USD 0.23B
FLCV Federated Hermes ETF Trus.. 2.21 % 0.00 %

N/A

USD 0.03B
HEAL:SW iShares Healthcare Innova.. 2.19 % 0.00 %

N/A

USD 1.05B
RAYD Rayliant Quantitative Dev.. 2.18 % 0.00 %

N/A

USD 0.09B
ABFL Abacus FCF Leaders ETF 2.16 % 0.00 %

N/A

N/A
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
RSPH Invesco S&P 500 Equal Wei.. 1.95 % 0.00 %

N/A

USD 0.83B
INCM:AU BetaShares Global Income .. 1.80 % 0.00 %

N/A

USD 0.03B
ZHU:CA BMO Equal Weight US Healt.. 1.76 % 0.00 %

N/A

CAD 0.01B
ZUH:CA BMO Equal Weight US Healt.. 1.74 % 0.39 %

N/A

CAD 0.22B
ESMV iShares ESG MSCI USA Min .. 1.73 % 0.00 %

N/A

USD 8.61M
AVLV American Century ETF Trus.. 1.69 % 0.00 %

N/A

USD 5.70B
CBUI:XETRA iShares MSCI World Value .. 1.68 % 0.00 %

N/A

USD 0.26B
IQSA:LSE Invesco Quantitative Stra.. 1.61 % 0.00 %

N/A

USD 0.79B
MVEW:LSE iShares Edge MSCI World M.. 1.59 % 0.00 %

N/A

USD 0.47B
CYH:CA iShares Global Monthly Di.. 1.58 % 0.66 %

N/A

CAD 0.15B
DIVG Invesco Exchange-Traded F.. 1.57 % 0.00 %

N/A

USD 3.14M
MVEC:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.47B
MVWE:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.07B
DGVA:AU Dimensional Global Value .. 0.99 % 0.00 %

N/A

N/A
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

N/A

N/A
RSPE Invesco Exchange-Traded F.. 0.73 % 0.00 %

N/A

USD 0.02B
PAPI Morgan Stanley ETF Trust 0.64 % 0.00 %

N/A

USD 0.14B
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

N/A

N/A
FVD:LSE First Trust Value Line® .. 0.52 % 0.00 %

N/A

USD 7.37M
UBBB:PA Amundi Index Solutions - .. 0.46 % 0.00 %

N/A

USD 0.13B
JPGL:LSE JPM Global Equity Multi-F.. 0.38 % 0.00 %

N/A

USD 0.19B
DFVE DoubleLine ETF Trust 0.28 % 0.00 %

N/A

USD 0.01B
EUSA iShares MSCI USA Equal We.. 0.20 % 0.15 %

N/A

USD 1.21B
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.39B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.06B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.30M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 6.39B
IBCD 0.00 % 0.10 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

N/A

USD 0.66B
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
JIGB 0.00 % 0.14 %

N/A

N/A
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

N/A

USD 1.82B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

N/A

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.22B
FCW:CA 0.00 % 0.90 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F 0.00 % 0.00 %

N/A

N/A
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

N/A
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

N/A
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

N/A

USD 9.39M
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

N/A
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
FLSP Franklin Liberty Systemat.. 0.00 % 0.00 %

N/A

USD 0.31B
HDIV 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 3.09M
KVLE KFA Value Line Dynamic Co.. 0.00 % 0.00 %

N/A

USD 0.03B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.08B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

N/A

USD 0.02B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.65% 100% F 91% A-
Dividend Return 0.86% 33% F 58% F
Total Return 21.50% 100% F 92% A
Trailing 12 Months  
Capital Gain 51.23% 100% F 89% A-
Dividend Return 4.21% 75% C 71% C-
Total Return 55.43% 100% F 90% A-
Trailing 5 Years  
Capital Gain 52.66% 86% B+ 59% D-
Dividend Return 20.10% 80% B- 58% F
Total Return 72.75% 86% B+ 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 2.17% 80% B- 45% F
Dividend Return 5.75% 80% B- 51% F
Total Return 3.58% 80% B- 73% C
Risk Return Profile  
Volatility (Standard Deviation) 25.82% 60% D- 69% C-
Risk Adjusted Return 22.26% 70% C- 55% F
Market Capitalization 142.46B 63% D 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector